- $4.43bn
- $4.18bn
- $914.52m
- 90
- 24
- 39
- 50
Annual income statement for Cognex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 811 | 1,037 | 1,006 | 838 | 915 |
| Cost of Revenue | |||||
| Gross Profit | 605 | 760 | 722 | 601 | 626 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 640 | 722 | 760 | 707 | 799 |
| Operating Profit | 171 | 315 | 246 | 131 | 115 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 187 | 319 | 251 | 135 | 131 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 176 | 280 | 216 | 113 | 106 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 176 | 280 | 216 | 113 | 106 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 176 | 280 | 216 | 113 | 106 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 1.19 | 1.56 | 1.34 | 0.614 | 0.615 |
| Dividends per Share | |||||
| Special Dividends per Share |